TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Bionord Biokemi AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
41,319
|
43,933
|
46,601 |
| Financial expenses |
0
|
1
|
7 |
| Earnings before taxes |
4,896
|
4,730
|
4,787 |
| EBITDA |
4,847
|
4,734
|
4,829 |
| Total assets |
18,321
|
16,731
|
19,279 |
| Current assets |
16,698
|
15,052
|
17,569 |
| Current liabilities |
5,964
|
4,854
|
8,046 |
| Equity capital |
10,434
|
10,055
|
9,557 |
| - share capital |
325
|
336
|
334 |
| Employees (average) |
5
|
6
|
5 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
57.0%
|
60.1%
|
49.6% |
| Turnover per employee |
8,264
|
7,322
|
9,320 |
| Profit as a percentage of turnover |
11.8%
|
10.8%
|
10.3% |
| Return on assets (ROA) |
26.7%
|
28.3%
|
24.9% |
| Current ratio |
280.0%
|
310.1%
|
218.4% |
| Return on equity (ROE) |
46.9%
|
47.0%
|
50.1% |
| Change turnover |
-1,161
|
-2,908
|
11,107 |
| Change turnover % |
-3%
|
-6%
|
31% |
| Chg. No. of employees |
-1
|
1
|
0 |
| Chg. No. of employees % |
-17%
|
20%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.